Tredegar Reports Fourth Quarter and Full Year 2021 Results
Tredegar Corporation (NYSE: TG) reported its fourth quarter and full year 2021 financial results, showing a substantial increase in net income from continuing operations of $21.4 million ($0.63 per diluted share), compared to $6.5 million ($0.19 per diluted share) a year prior. Full year net income was $57.9 million ($1.72 per diluted share), reversing a net loss of $16.8 million in 2020. However, EBITDA from ongoing operations declined across several segments. The company continues to face challenges with supply chain issues, labor shortages, and inflation, impacting profitability. Debt reduced by approximately $80 million in 2021.
- Fourth quarter 2021 net income from continuing operations increased to $21.4 million ($0.63 per diluted share) from $6.5 million a year earlier.
- 2021 full year net income was $57.9 million ($1.72 per diluted share), a significant improvement from a net loss of $16.8 million in 2020.
- Debt, net of cash, declined by approximately $80 million during 2021.
- Robust orders and backlog remain, indicating potential future growth.
- EBITDA from ongoing operations decreased in Aluminum Extrusions, PE Films, and Flexible Packaging Films segments.
- Labor shortages and supply chain disruptions continue to hinder production efficiency.
- PE Films segment experienced a decline in sales volume and EBITDA, primarily due to customer product transitions and higher resin costs.
- Non-residential B&C sales volume declined 4% in Q4 2021 and 11% for the full year compared to 2020.
Fourth quarter 2021 net income from continuing operations was
Full year 2021 net income from continuing operations was
Fourth Quarter Financial Results Highlights
-
Earnings before interest, taxes, depreciation and amortization (“EBITDA”) from ongoing operations for Aluminum Extrusions of
was$10.9 million lower than the fourth quarter of 2020$2.8 million
-
EBITDA from ongoing operations for
PE Films of was$6.7 million lower than the fourth quarter of 2020$4.5 million
-
EBITDA from ongoing operations for
Flexible Packaging Films of was$6.4 million lower than the fourth quarter of 2020$1.7 million
THE IMPACT OF COVID-19 AND RELATED FINANCIAL CONSIDERATIONS
Essential Business and Employee Considerations
The Company’s priorities during the coronavirus (“COVID-19”) pandemic continue to be to protect the health and safety of employees while keeping its manufacturing sites open due to the essential nature of many of its products. The Company has continued to manufacture the full range of products at its facilities.
The Company’s protocols to protect the health and well-being of its employees from COVID-19 continue to evolve as the
The Company has engaged in an education campaign that provides employees with the most accurate and up-to-date information related to COVID-19 vaccines and has offered different monetary and/or time-away-from-work incentives to encourage employees to get vaccinated with the primary dose(s) and to get a booster shot once eligible. The Company will continue to monitor available information to assess safeguards that may be taken to try to prevent a COVID-19 outbreak in the workplace.
Aluminum Extrusions, also known as
All three of the Company's business segments are managing through supply chain disruptions and escalating costs, including raw material cost increases, shortages, transportation cost increases and delays. To offset growing cost pressures,
Financial Considerations
Approximately
The Surface Protection component of
At Terphane, the Company believes that the pandemic-related surge in demand for flexible packaging films that began in early 2020 returned to lower pre-pandemic levels during the second quarter of 2021.
OPERATIONS REVIEW
Aluminum Extrusions
Aluminum Extrusions produces high-quality, soft-alloy and medium-strength custom fabricated and finished aluminum extrusions primarily for the following markets: B&C, automotive, and specialty (which consists of consumer durables, machinery and equipment, electrical and renewable energy, and distribution end-use products). A summary of fourth quarter and full year results for Aluminum Extrusions is provided below:
|
|
Three Months Ended |
|
Favorable/ |
|
Year Ended |
|
Favorable/ |
||||||||||||||
(In thousands, except percentages) |
|
|
|
(Unfavorable) |
|
|
|
(Unfavorable) |
||||||||||||||
|
|
2021 |
|
|
|
2020 |
|
|
% Change |
|
|
2021 |
|
|
|
2020 |
|
|
% Change |
|||
Sales volume (lbs) |
|
|
44,576 |
|
|
|
46,408 |
|
|
(3.9 |
)% |
|
|
183,367 |
|
|
|
186,391 |
|
|
(1.6 |
)% |
Net sales |
|
$ |
144,832 |
|
|
$ |
116,145 |
|
|
24.7 |
% |
|
$ |
539,325 |
|
|
$ |
455,711 |
|
|
18.3 |
% |
Ongoing operations: |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
EBITDA |
|
$ |
10,886 |
|
|
$ |
13,641 |
|
|
(20.2 |
)% |
|
$ |
55,948 |
|
|
$ |
55,137 |
|
|
1.5 |
% |
Depreciation & amortization |
|
|
(4,210 |
) |
|
|
(4,771 |
) |
|
11.8 |
% |
|
|
(16,272 |
) |
|
|
(17,403 |
) |
|
6.5 |
% |
EBIT* |
|
$ |
6,676 |
|
|
$ |
8,870 |
|
|
(24.7 |
)% |
|
$ |
39,676 |
|
|
$ |
37,734 |
|
|
5.1 |
% |
Capital expenditures |
|
$ |
6,957 |
|
|
$ |
5,547 |
|
|
|
|
$ |
18,914 |
|
|
$ |
10,260 |
|
|
|
||
* See the attached net sales and EBITDA from ongoing operations by segment statements for a reconciliation of this non-GAAP measure to GAAP. |
Fourth Quarter 2021 Results vs. Fourth Quarter 2020 Results
Net sales (sales less freight) in the fourth quarter of 2021 increased by
EBITDA from ongoing operations in the fourth quarter of 2021 decreased by
Full Year 2021 Results vs. Full Year 2020 Results
Net sales in 2021 increased by
EBITDA from ongoing operations in 2021 increased by
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for
|
|
Three Months Ended |
|
Favorable/ |
|
Year Ended |
|
Favorable/ |
||||||||||||||
(In thousands, except percentages) |
|
|
|
(Unfavorable) |
|
|
|
(Unfavorable) |
||||||||||||||
|
|
2021 |
|
|
|
2020 |
|
|
% Change |
|
|
2021 |
|
|
|
2020 |
|
|
% Change |
|||
Sales volume (lbs) |
|
|
9,363 |
|
|
|
11,827 |
|
|
(20.8 |
)% |
|
|
39,429 |
|
|
|
45,175 |
|
|
(12.7 |
)% |
Net sales |
|
$ |
31,035 |
|
|
$ |
35,843 |
|
|
(13.4 |
)% |
|
$ |
118,920 |
|
|
$ |
139,288 |
|
|
(14.6 |
)% |
Ongoing operations: |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
EBITDA |
|
$ |
6,659 |
|
|
$ |
11,179 |
|
|
(40.4 |
)% |
|
$ |
27,694 |
|
|
$ |
45,107 |
|
|
(38.6 |
)% |
Depreciation & amortization |
|
|
(1,582 |
) |
|
|
(1,894 |
) |
|
16.5 |
% |
|
|
(6,263 |
) |
|
|
(6,762 |
) |
|
7.4 |
% |
EBIT* |
|
$ |
5,077 |
|
|
$ |
9,285 |
|
|
(45.3 |
)% |
|
$ |
21,431 |
|
|
$ |
38,345 |
|
|
(44.1 |
)% |
Capital expenditures |
|
$ |
240 |
|
|
$ |
1,147 |
|
|
|
|
$ |
2,997 |
|
|
$ |
6,024 |
|
|
|
||
* See the attached net sales and EBITDA from ongoing operations by segment statements for a reconciliation of this non-GAAP measure to GAAP. |
Fourth Quarter 2021 Results vs. Fourth Quarter 2020 Results
Net sales decreased by
EBITDA from ongoing operations in the fourth quarter of 2021 decreased by
-
A
decrease from Surface Protection associated with lower sales and unfavorable mix for products unrelated to previously disclosed customer product transitions ($6.8 million ), lower sales associated with the customer product transitions ($4.7 million ), higher freight and packaging expense ($0.2 million ), the pass-through lag associated with higher resin costs ($0.9 million ), and lower productivity ($0.4 million );$0.4 million
-
A
increase from$1.6 million Pottsville Packaging primarily related to favorable sales mix ( ), a benefit from the pass-through lag associated with higher resin costs (benefit of$0.4 million in the fourth quarter of 2021 versus a charge of$0.1 million in the fourth quarter of 2020), and a benefit from inventories accounted for under the first-in first-out method (benefit of$0.2 million versus a charge of$0.5 million in the fourth quarter of 2020); and$0.5 million
-
A
favorable variance associated with the divestiture of Bright View Technologies at the end of 2020.$1.1 million
See discussion of Quantitative and Qualitative Disclosures About Market Risk in Item 7 of the Form 10-K for additional information on resin price trends.
Customer Product Transitions and Other Factors in Surface Protection
The Surface Protection component of
The Company previously reported the risk that a portion of its film products used in surface protection applications would be made obsolete by customer product transitions to less costly alternative processes or materials. The Company estimates that these transitions, which principally relate to one customer, adversely impacted EBITDA from ongoing operations for
The Surface Protection business is also experiencing competitive pricing pressures, unrelated to the customer product transitions, that are expected to adversely impact EBITDA from ongoing operations by approximately
Full Year 2021 Results vs. Full Year 2020 Results
Net sales in 2021 decreased by
EBITDA from ongoing operations in 2021 decreased by
-
A
decrease from Surface Protection primarily related to lower sales and unfavorable mix associated with the customer product transitions ($19.4 million ), lower sales and unfavorable mix for products unrelated to customer product transitions ($14.8 million ), margin erosion associated with higher resin costs that occurred before the resin index pricing plan was fully implemented ($3.4 million ), the pass-through lag associated with higher resin costs ($1.4 million ), and higher freight expense ($1.4 million ), partially offset by production efficiencies and cost savings ($1.0 million ) and lower research and development spend ($1.9 million );$0.4 million
-
A
increase from$0.1 million Pottsville Packaging ; and
-
A
favorable variance associated with the divestiture of Bright View Technologies at the end of 2020.$2.7 million
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for
|
Three Months Ended |
|
Favorable/ (Unfavorable) % Change |
|
Year Ended |
|
Favorable/ (Unfavorable) % Change |
||||||||||||||
(In thousands, except percentages) |
|
|
|
|
|||||||||||||||||
|
2021 |
|
|
|
2020 |
|
|
|
2021 |
|
|
|
2020 |
|
|
||||||
Sales volume (lbs) |
|
25,902 |
|
|
|
28,026 |
|
|
(7.6 |
)% |
|
|
104,569 |
|
|
|
113,115 |
|
|
(7.6 |
)% |
Net sales |
$ |
37,418 |
|
|
$ |
34,072 |
|
|
9.8 |
% |
|
$ |
139,978 |
|
|
$ |
134,605 |
|
|
4.0 |
% |
Ongoing operations: |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
EBITDA |
$ |
6,388 |
|
|
$ |
8,051 |
|
|
(20.7 |
)% |
|
$ |
31,684 |
|
|
$ |
30,645 |
|
|
3.4 |
% |
Depreciation & amortization |
|
(523 |
) |
|
|
(455 |
) |
|
(14.9 |
)% |
|
|
(1,988 |
) |
|
|
(1,761 |
) |
|
(12.9 |
)% |
EBIT* |
$ |
5,865 |
|
|
$ |
7,596 |
|
|
(22.8 |
)% |
|
$ |
29,696 |
|
|
$ |
28,884 |
|
|
2.8 |
% |
Capital expenditures |
$ |
1,320 |
|
|
$ |
2,511 |
|
|
|
|
$ |
5,603 |
|
|
$ |
4,959 |
|
|
|
||
* See the attached net sales and EBITDA from ongoing operations by segment statements for a reconciliation of this non-GAAP measure to GAAP. |
Fourth Quarter 2021 Results vs. Fourth Quarter 2020 Results
Sales volume declined by
EBITDA from ongoing operations in the fourth quarter of 2021 decreased by
-
Higher raw material costs (
), higher variable costs ($5.3 million ) and lower sales volume ($1.4 million ), partially offset by higher selling prices ($1.3 million ) from the pass-through of higher resin costs, favorable absorption of fixed costs ($3.3 million ) and lower selling, general and administration expenses ($0.9 million );$0.3 million
-
Net favorable foreign currency translation of Real-denominated operating costs (
); and$1.1 million
-
Higher foreign currency transaction gains (
) in the fourth quarter of 2021 versus the fourth quarter of 2020.$0.9 million
Full Year 2021 Results vs. Full Year 2020 Results
Sales volume declined by
EBITDA from ongoing operations in 2021 increased by
-
Higher selling prices from the pass-through of higher resin costs (
), favorable product mix ($11.2 million ) and lower selling, general, and administration expenses ($2.0 million ), partially offset by higher raw material costs ($0.7 million ), lower sales volume ($12.8 million ) and higher variable costs ($4.9 million );$1.7 million
-
Net favorable currency translation of Real-denominated operating costs (
);$5.9 million
-
Higher foreign currency transaction gains (
) in 2021 versus 2020; and$1.2 million
-
Lower value-added tax credits received in 2021 (
) versus 2020.$0.5 million
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for Terphane are projected to be
Corporate Expenses, Investments, Interest and Taxes
Corporate expenses, net, decreased
Interest expense was
The effective tax rate used to compute income taxes for continuing operations in 2021 was
Pension expense was
As of
Total debt was
FORWARD-LOOKING AND CAUTIONARY STATEMENTS
Some of the information contained in this press release may constitute “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. When the Company uses the words “believe,” “estimate,” “anticipate,” “appear to,” “expect,” “project,” “plan,” “likely,” “may” and similar expressions, it does so to identify forward-looking statements. Such statements are based on the Company's then current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those addressed in the forward-looking statements. It is possible that the Company's actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in or implied by these forward-looking statements. In addition, the Company's current projections for its businesses could be materially affected by the highly uncertain impact of the COVID-19 pandemic. As a consequence, the Company's results could differ significantly from its projections, depending on, among other things, the ultimate impact of the pandemic on employees, supply chains, customers and the
- loss or gain of sales to significant customers on which the Company’s business is highly dependent;
- inability to achieve sales to new customers to replace lost business;
- inability to develop, efficiently manufacture and deliver new products at competitive prices;
- failure of the Company’s customers to achieve success or maintain market share;
- failure to protect our intellectual property rights;
-
risks of doing business in countries outside the
U.S. that affect our international operations;
- political, economic, and regulatory factors concerning the Company’s products;
- uncertain economic conditions in countries in which the Company does business;
- competition from other manufacturers, including manufacturers in lower-cost countries and manufacturers benefiting from government subsidies;
- impact of fluctuations in foreign exchange rates;
- movement of pension plan assets and liabilities up through initiating hedging activities to fix underfunding amounts and assumptions thereafter relating to differences between the ultimate settlement benefit obligation and the projected benefit obligation, census data, administrative costs, the effectiveness of hedging activities and discounts required to liquidate non-public securities held by the plan;
- an increase in the operating costs incurred by the Company’s business units, including, for example, the cost of raw materials and energy;
- inability to successfully identify, complete or integrate strategic acquisitions; failure to realize the expected benefits of such acquisitions and assumption of unanticipated risks in such acquisitions;
- disruptions to the Company’s manufacturing facilities, including those resulting from labor shortages;
- the impact of public health epidemics on employees, production and the global economy, such as the COVID-19 pandemic;
- an information technology system failure or breach;
-
the impact of the imposition of tariffs and sanctions on imported aluminum ingot used by
Bonnell Aluminum ;
-
the impact of new tariffs, duties or other trade restrictions imposed as a result of trade tensions between the
U.S. and other countries;
-
the termination of anti-dumping duties on products imported to
Brazil that compete with products produced byFlexible Packaging ;
- failure to establish and maintain effective internal control over financial reporting;
and the other factors discussed in the reports Tredegar files with or furnishes to the
Tredegar does not undertake, and expressly disclaims any duty, to update any forward-looking statement made in this press release to reflect any change in management’s expectations or any change in conditions, assumptions or circumstances on which such statements are based, except as required by applicable law.
To the extent that the financial information portion of this press release contains non-GAAP financial measures, it also presents both the most directly comparable financial measures calculated and presented in accordance with GAAP and a quantitative reconciliation of the difference between any such non-GAAP measures and such comparable GAAP financial measures. Reconciliations of non-GAAP financial measures are provided in the Notes to the Financial Tables included with this press release and can also be found within “Presentations” in the “Investors” section of our website, www.tredegar.com.
Tredegar uses its website as a channel of distribution of material company information. Financial information and other material information regarding Tredegar is posted on and assembled in the “Investors” section of its website.
|
||||||||||||||||
Condensed Consolidated Statements of Income |
||||||||||||||||
(In Thousands, Except Per-Share Data) |
||||||||||||||||
(Unaudited) |
||||||||||||||||
|
|
|
|
|
||||||||||||
|
|
Three Months Ended |
|
Year Ended |
||||||||||||
|
|
|
|
|
||||||||||||
|
|
|
2021 |
|
|
|
2020 |
|
|
|
2021 |
|
|
|
2020 |
|
Sales |
|
$ |
220,986 |
|
|
$ |
192,524 |
|
|
$ |
826,455 |
|
|
$ |
755,290 |
|
Other income (expense), net (c)(d)(h) |
|
|
11,104 |
|
|
|
(3,396 |
) |
|
|
20,376 |
|
|
|
(67,294 |
) |
|
|
|
232,090 |
|
|
|
189,128 |
|
|
|
846,831 |
|
|
|
687,996 |
|
|
|
|
|
|
|
|
|
|
||||||||
Cost of goods sold (c) |
|
|
178,957 |
|
|
|
143,755 |
|
|
|
649,690 |
|
|
|
558,967 |
|
Freight |
|
|
7,701 |
|
|
|
6,464 |
|
|
|
28,232 |
|
|
|
25,686 |
|
Selling, R&D and general expenses (c) |
|
|
21,117 |
|
|
|
24,927 |
|
|
|
81,311 |
|
|
|
92,644 |
|
Amortization of identifiable intangibles (j) |
|
|
(466 |
) |
|
|
753 |
|
|
|
1,704 |
|
|
|
3,017 |
|
Pension and postretirement benefits |
|
|
3,540 |
|
|
|
4,019 |
|
|
|
14,160 |
|
|
|
14,720 |
|
Interest expense |
|
|
831 |
|
|
|
989 |
|
|
|
3,386 |
|
|
|
2,587 |
|
Asset impairments and costs associated with exit and disposal activities, net of adjustments (c) |
|
|
495 |
|
|
|
1,651 |
|
|
|
1,127 |
|
|
|
1,725 |
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
13,696 |
|
|
|
|
212,175 |
|
|
|
182,558 |
|
|
|
779,610 |
|
|
|
713,042 |
|
Income (loss) from continuing operations before income taxes |
|
|
19,915 |
|
|
|
6,570 |
|
|
|
67,221 |
|
|
|
(25,046 |
) |
Income tax expense (benefit)(c) |
|
|
(1,443 |
) |
|
|
95 |
|
|
|
9,284 |
|
|
|
(8,213 |
) |
Net income (loss) from continuing operations |
|
|
21,358 |
|
|
|
6,475 |
|
|
|
57,937 |
|
|
|
(16,833 |
) |
Income (loss) from discontinued operations, net of tax |
|
|
(6 |
) |
|
|
(5,580 |
) |
|
|
(111 |
) |
|
|
(58,611 |
) |
Net income (loss) |
|
$ |
21,352 |
|
|
$ |
895 |
|
|
$ |
57,826 |
|
|
$ |
(75,444 |
) |
|
|
|
|
|
|
|
|
|
||||||||
Earnings (loss) per share: |
|
|
|
|
|
|
|
|
||||||||
Basic: |
|
|
|
|
|
|
|
|
||||||||
Continuing operations |
|
$ |
0.64 |
|
|
$ |
0.19 |
|
|
$ |
1.72 |
|
|
$ |
(0.51 |
) |
Discontinued operations |
|
|
— |
|
|
|
(0.17 |
) |
|
|
— |
|
|
|
(1.75 |
) |
Basic earnings (loss) per share |
|
$ |
0.64 |
|
|
$ |
0.02 |
|
|
$ |
1.72 |
|
|
$ |
(2.26 |
) |
Diluted: |
|
|
|
|
|
|
|
|
||||||||
Continuing operations |
|
$ |
0.63 |
|
|
$ |
0.19 |
|
|
$ |
1.72 |
|
|
$ |
(0.51 |
) |
Discontinued operations |
|
|
— |
|
|
|
(0.17 |
) |
|
|
— |
|
|
|
(1.75 |
) |
Diluted earnings (loss) per share |
|
$ |
0.63 |
|
|
$ |
0.02 |
|
|
$ |
1.72 |
|
|
$ |
(2.26 |
) |
|
|
|
|
|
|
|
|
|
||||||||
Shares used to compute earnings (loss) per share: |
|
|
|
|
|
|
|
|
||||||||
Basic |
|
|
33,628 |
|
|
|
33,421 |
|
|
|
33,563 |
|
|
|
33,402 |
|
Diluted |
|
|
33,648 |
|
|
|
33,485 |
|
|
|
33,670 |
|
|
|
33,402 |
|
|
||||||||||||||||
|
||||||||||||||||
(In Thousands) |
||||||||||||||||
(Unaudited) |
||||||||||||||||
|
|
|
|
|
||||||||||||
|
|
Three Months Ended |
|
Year Ended |
||||||||||||
|
|
|
|
|
||||||||||||
|
|
|
2021 |
|
|
|
2020 |
|
|
|
2021 |
|
|
|
2020 |
|
|
|
|
|
|
|
|
|
|
||||||||
Aluminum Extrusions |
|
$ |
144,832 |
|
|
$ |
116,145 |
|
|
$ |
539,325 |
|
|
$ |
455,711 |
|
|
|
|
31,035 |
|
|
|
35,843 |
|
|
|
118,920 |
|
|
|
139,288 |
|
|
|
|
37,418 |
|
|
|
34,072 |
|
|
|
139,978 |
|
|
|
134,605 |
|
Total net sales |
|
|
213,285 |
|
|
|
186,060 |
|
|
|
798,223 |
|
|
|
729,604 |
|
Add back freight |
|
|
7,701 |
|
|
|
6,464 |
|
|
|
28,232 |
|
|
|
25,686 |
|
Sales as shown in the Condensed Consolidated Statements of Income |
|
$ |
220,986 |
|
|
$ |
192,524 |
|
|
$ |
826,455 |
|
|
$ |
755,290 |
|
|
|
|
|
|
|
|
|
|
||||||||
EBITDA from Ongoing Operations |
|
|
|
|
|
|
|
|
||||||||
Aluminum Extrusions: |
|
|
|
|
|
|
|
|
||||||||
Ongoing operations: |
|
|
|
|
|
|
|
|
||||||||
EBITDA (b) |
|
$ |
10,886 |
|
|
$ |
13,641 |
|
|
$ |
55,948 |
|
|
$ |
55,137 |
|
Depreciation & amortization |
|
|
(4,210 |
) |
|
|
(4,771 |
) |
|
|
(16,272 |
) |
|
|
(17,403 |
) |
EBIT (b) |
|
|
6,676 |
|
|
|
8,870 |
|
|
|
39,676 |
|
|
|
37,734 |
|
Plant shutdowns, asset impairments, restructurings and other (c) |
|
|
3,461 |
|
|
|
(869 |
) |
|
|
3,237 |
|
|
|
(3,506 |
) |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(13,696 |
) |
|
|
|
|
|
|
|
|
|
||||||||
Ongoing operations: |
|
|
|
|
|
|
|
|
||||||||
EBITDA (b) |
|
|
6,659 |
|
|
|
11,179 |
|
|
|
27,694 |
|
|
|
45,107 |
|
Depreciation & amortization |
|
|
(1,582 |
) |
|
|
(1,894 |
) |
|
|
(6,263 |
) |
|
|
(6,762 |
) |
EBIT (b) |
|
|
5,077 |
|
|
|
9,285 |
|
|
|
21,431 |
|
|
|
38,345 |
|
Plant shutdowns, asset impairments, restructurings and other (c) |
|
|
86 |
|
|
|
(1,751 |
) |
|
|
(371 |
) |
|
|
(1,974 |
) |
|
|
|
|
|
|
|
|
|
||||||||
Ongoing operations: |
|
|
|
|
|
|
|
|
||||||||
EBITDA (b) |
|
|
6,388 |
|
|
|
8,051 |
|
|
|
31,684 |
|
|
|
30,645 |
|
Depreciation & amortization |
|
|
(523 |
) |
|
|
(455 |
) |
|
|
(1,988 |
) |
|
|
(1,761 |
) |
EBIT (b) |
|
|
5,865 |
|
|
|
7,596 |
|
|
|
29,696 |
|
|
|
28,884 |
|
Plant shutdowns, asset impairments, restructurings and other (c) |
|
|
32 |
|
|
|
(4 |
) |
|
|
8,439 |
|
|
|
(18 |
) |
Total |
|
|
21,197 |
|
|
|
23,127 |
|
|
|
102,108 |
|
|
|
85,769 |
|
Interest income |
|
|
33 |
|
|
|
1 |
|
|
|
73 |
|
|
|
44 |
|
Interest expense |
|
|
831 |
|
|
|
989 |
|
|
|
3,386 |
|
|
|
2,587 |
|
Gain (loss) on investment in kaléo (d) |
|
|
11,583 |
|
|
|
100 |
|
|
|
12,780 |
|
|
|
(60,900 |
) |
Loss on sale of Bright View Technologies (i) |
|
|
— |
|
|
|
(2,299 |
) |
|
|
— |
|
|
|
(2,299 |
) |
Stock option-based compensation costs |
|
|
675 |
|
|
|
394 |
|
|
|
2,495 |
|
|
|
2,161 |
|
Corporate expenses, net (c) |
|
|
11,392 |
|
|
|
12,976 |
|
|
|
41,859 |
|
|
|
42,912 |
|
Income (loss) from continuing operations before income taxes |
|
|
19,915 |
|
|
|
6,570 |
|
|
|
67,221 |
|
|
|
(25,046 |
) |
Income tax expense (benefit) |
|
|
(1,443 |
) |
|
|
95 |
|
|
|
9,284 |
|
|
|
(8,213 |
) |
Net income (loss) from continuing operations |
|
|
21,358 |
|
|
|
6,475 |
|
|
|
57,937 |
|
|
|
(16,833 |
) |
Income (loss) from discontinued operations, net of tax |
|
|
(6 |
) |
|
|
(5,580 |
) |
|
|
(111 |
) |
|
|
(58,611 |
) |
Net income (loss) |
|
$ |
21,352 |
|
|
$ |
895 |
|
|
$ |
57,826 |
|
|
$ |
(75,444 |
) |
|
||||||
Condensed Consolidated Balance Sheets |
||||||
(In Thousands) |
||||||
(Unaudited) |
||||||
|
|
|
|
|
||
|
|
|
|
|
||
Assets |
|
|
|
|
||
Cash & cash equivalents |
|
$ |
30,521 |
|
$ |
11,846 |
Accounts & other receivables, net |
|
|
103,312 |
|
|
86,327 |
Income taxes recoverable |
|
|
2,558 |
|
|
2,807 |
Inventories |
|
|
88,569 |
|
|
66,437 |
Prepaid expenses & other |
|
|
11,275 |
|
|
19,679 |
Current assets of discontinued operations |
|
|
178 |
|
|
1,339 |
Total current assets |
|
|
236,413 |
|
|
188,435 |
Property, plant & equipment, net |
|
|
170,381 |
|
|
166,545 |
Right-of-use leased assets |
|
|
13,847 |
|
|
16,037 |
Investment in kaléo (cost basis of |
|
|
— |
|
|
34,600 |
Identifiable intangible assets, net (j) |
|
|
14,152 |
|
|
18,820 |
|
|
|
70,608 |
|
|
67,708 |
Deferred income taxes |
|
|
15,723 |
|
|
19,068 |
Other assets |
|
|
2,460 |
|
|
3,506 |
Non-current assets of discontinued operations |
|
|
— |
|
|
151 |
Total assets |
|
$ |
523,584 |
|
$ |
514,870 |
Liabilities and Shareholders’ Equity |
|
|
|
|
||
Accounts payable |
|
$ |
123,760 |
|
$ |
89,702 |
Accrued expenses |
|
|
33,104 |
|
|
40,741 |
Lease liability, short-term |
|
|
2,158 |
|
|
2,082 |
Income taxes payable |
|
|
9,333 |
|
|
706 |
Current liabilities of discontinued operations |
|
|
193 |
|
|
7,521 |
Total current liabilities |
|
|
168,548 |
|
|
140,752 |
Lease liability, long-term |
|
|
12,831 |
|
|
14,949 |
Long-term debt |
|
|
73,000 |
|
|
134,000 |
Pension and other postretirement benefit obligations, net |
|
|
78,265 |
|
|
110,585 |
Other non-current liabilities |
|
|
6,218 |
|
|
5,529 |
Shareholders’ equity |
|
|
184,722 |
|
|
109,055 |
Total liabilities and shareholders’ equity |
|
$ |
523,584 |
|
$ |
514,870 |
|
||||||||
Condensed Consolidated Statements of Cash Flows |
||||||||
(In Thousands) |
||||||||
(Unaudited) |
||||||||
|
|
|
||||||
|
|
Year Ended |
||||||
|
|
|
2021 |
|
|
|
2020 |
|
Cash flows from operating activities: |
|
|
|
|
||||
Net income (loss) |
|
$ |
57,826 |
|
|
$ |
(75,444 |
) |
Adjustments for noncash items: |
|
|
|
|
||||
Depreciation |
|
|
22,080 |
|
|
|
28,940 |
|
Amortization of intangibles |
|
|
1,704 |
|
|
|
3,017 |
|
Reduction of right-of-use assets |
|
|
2,086 |
|
|
|
2,753 |
|
|
|
|
— |
|
|
|
13,696 |
|
Deferred income taxes |
|
|
(4,944 |
) |
|
|
(16,892 |
) |
Accrued pension and postretirement benefits |
|
|
14,160 |
|
|
|
14,720 |
|
Stock-based compensation expense |
|
|
5,167 |
|
|
|
5,402 |
|
(Gain) loss on investment in kaléo |
|
|
(12,462 |
) |
|
|
60,900 |
|
Loss on sale of divested businesses |
|
|
— |
|
|
|
52,326 |
|
Changes in assets and liabilities: |
|
|
|
|
||||
Accounts and other receivables |
|
|
(16,993 |
) |
|
|
(335 |
) |
Inventories |
|
|
(23,132 |
) |
|
|
(4,366 |
) |
Income taxes recoverable/payable |
|
|
8,956 |
|
|
|
1,617 |
|
Prepaid expenses and other |
|
|
3,612 |
|
|
|
(2,203 |
) |
Accounts payable and accrued expenses |
|
|
19,835 |
|
|
|
4,045 |
|
Lease liability |
|
|
(1,935 |
) |
|
|
(3,049 |
) |
Pension and postretirement benefit plan contributions |
|
|
(5,687 |
) |
|
|
(12,681 |
) |
Other, net |
|
|
310 |
|
|
|
1,927 |
|
Net cash provided by operating activities |
|
|
70,583 |
|
|
|
74,373 |
|
Cash flows from investing activities: |
|
|
|
|
||||
Capital expenditures |
|
|
(27,361 |
) |
|
|
(23,355 |
) |
Proceeds on sale of investment in kaléo |
|
|
47,062 |
|
|
|
— |
|
Proceeds from the sale of assets |
|
|
4,749 |
|
|
|
— |
|
Proceeds from the sale of businesses |
|
|
— |
|
|
|
56,236 |
|
Net cash provided by investing activities |
|
|
24,450 |
|
|
|
32,881 |
|
Cash flows from financing activities: |
|
|
|
|
||||
Borrowings |
|
|
75,500 |
|
|
|
162,250 |
|
Debt principal payments |
|
|
(136,500 |
) |
|
|
(70,250 |
) |
Dividends paid |
|
|
(16,167 |
) |
|
|
(216,049 |
) |
Debt financing costs |
|
|
|
|
(693 |
) |
||
Other |
|
|
325 |
|
|
|
(850 |
) |
Net cash used in financing activities |
|
|
(76,842 |
) |
|
|
(125,592 |
) |
Effect of exchange rate changes on cash |
|
|
484 |
|
|
|
(1,238 |
) |
Increase (decrease) in cash and cash equivalents |
|
|
18,675 |
|
|
|
(19,576 |
) |
Cash and cash equivalents at beginning of period |
|
|
11,846 |
|
|
|
31,422 |
|
Cash and cash equivalents at end of period |
|
$ |
30,521 |
|
|
$ |
11,846 |
|
Notes to the Financial Tables
(Unaudited)
(a) Tredegar’s presentation of net income (loss) and diluted earnings (loss) per share from ongoing operations are non-GAAP financial measures that exclude the effects of gains or losses associated with plant shutdowns, asset impairments and restructurings, gains or losses from the sale of assets, goodwill impairment charges, and other items (which includes gains and losses for an investment accounted for under the fair value method) which have been presented separately and removed from net income (loss) from continuing operations and diluted earnings (loss) per share as reported under GAAP. Net income (loss) and diluted earnings (loss) per share from ongoing operations are key financial and analytical measures used by management to gauge the operating performance of Tredegar’s ongoing operations. They are not intended to represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income (loss) from continuing operations or earnings (loss) per share as defined by GAAP. They exclude items that management believes do not relate to Tredegar’s ongoing operations. A reconciliation to net income (loss) and diluted earnings (loss) per share from ongoing operations for the three months and the years ended
|
|
Three Months Ended
|
|
Year Ended
|
||||||||||||
(In millions, except per share data) |
|
|
2021 |
|
|
|
2020 |
|
|
|
2021 |
|
|
|
2020 |
|
Net income (loss) from continuing operations as reported under GAAP1 |
|
$ |
21.4 |
|
|
$ |
6.5 |
|
|
$ |
57.9 |
|
|
$ |
(16.8 |
) |
After-tax effects of: |
|
|
|
|
|
|
|
|
||||||||
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
|
|
0.3 |
|
|
|
1.2 |
|
|
|
0.5 |
|
|
|
1.2 |
|
(Gains) losses from sale of assets and other: |
|
|
|
|
|
|
|
|
||||||||
(Gain) loss associated with the investment in kaléo |
|
|
(9.1 |
) |
|
|
(0.1 |
) |
|
|
(10.0 |
) |
|
|
47.6 |
|
Loss on sale of Bright View Technologies |
|
|
— |
|
|
|
1.8 |
|
|
|
— |
|
|
|
1.8 |
|
One-time tax credit in |
|
|
— |
|
|
|
— |
|
|
|
(6.6 |
) |
|
|
— |
|
Tax benefit associated with the release of a deferred tax valuation allowance on excess capital losses primarily due to sale of kaléo |
|
|
(5.5 |
) |
|
|
— |
|
|
|
(5.4 |
) |
|
|
— |
|
Other |
|
|
(0.9 |
) |
|
|
0.3 |
|
|
|
3.2 |
|
|
|
6.5 |
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
10.5 |
|
Net income (loss) from ongoing operations1 |
|
$ |
6.2 |
|
|
$ |
9.7 |
|
|
$ |
39.6 |
|
|
$ |
50.8 |
|
|
|
|
|
|
|
|
|
|
||||||||
Earnings (loss) from continuing operations per share as reported under GAAP (diluted) |
|
$ |
0.63 |
|
|
$ |
0.19 |
|
|
$ |
1.72 |
|
|
$ |
(0.51 |
) |
After-tax effects per diluted share of: |
|
|
|
|
|
|
|
|
||||||||
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
|
|
0.01 |
|
|
|
0.04 |
|
|
|
0.02 |
|
|
|
0.04 |
|
(Gains) losses from sale of assets and other: |
|
|
|
|
|
|
|
|
||||||||
(Gain) loss associated with the investment in kaléo |
|
|
(0.27 |
) |
|
|
— |
|
|
|
(0.30 |
) |
|
|
1.42 |
|
Loss on sale of Bright View Technologies |
|
|
— |
|
|
|
0.05 |
|
|
|
— |
|
|
|
0.05 |
|
One-time tax credit in |
|
|
— |
|
|
|
— |
|
|
|
(0.20 |
) |
|
|
— |
|
Tax benefit associated with the release of a deferred tax valuation allowance on excess capital losses primarily due to sale of kaléo |
|
|
(0.16 |
) |
|
|
— |
|
|
|
(0.16 |
) |
|
|
— |
|
Other |
|
|
(0.03 |
) |
|
|
0.01 |
|
|
|
0.10 |
|
|
|
0.19 |
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.32 |
|
Earnings (loss) per share from ongoing operations (diluted) |
|
$ |
0.18 |
|
|
$ |
0.29 |
|
|
$ |
1.18 |
|
|
$ |
1.51 |
|
|
(b) EBITDA (earnings before interest, taxes, depreciation and amortization) from ongoing operations is the key profitability metric used by the Company’s chief operating decision maker to assess segment financial performance. For more business segment information, see Note 13 in the Notes to Financial Statements in the Form 10-K.
EBIT (earnings before interest and taxes) from ongoing operations is a non-GAAP financial measure included in the accompanying tables and the reconciliation of segment financial information to consolidated results for the Company in the net sales and EBITDA from ongoing operations by segment statements. It is not intended to represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income (loss) from continuing operations as defined by GAAP. The Company believes that EBIT is a widely understood and utilized metric that is meaningful to certain investors and that including this financial metric in the reconciliation of management’s performance metric, EBITDA from ongoing operations, provides useful information to those investors that primarily utilize EBIT to analyze the Company’s core operations.
(c) Gains and losses associated with plant shutdowns, asset impairments, restructurings and other items for the three months and the years ended
|
Three Months Ended
|
Year Ended |
||||||||||
(in millions) |
Pre-Tax |
Net of Tax |
Pre-Tax |
Net of Tax |
||||||||
Aluminum Extrusions: |
|
|
|
|
||||||||
(Gains) losses from sale of assets, investment writedowns and other items: |
|
|
|
|
||||||||
Consulting expenses for ERP feasibility study1 |
$ |
0.3 |
|
$ |
0.2 |
|
$ |
0.3 |
|
$ |
0.2 |
|
Futura intangible amortization out-of-period adjustment6 |
|
(0.9 |
) |
|
(0.7 |
) |
|
(0.9 |
) |
|
(0.7 |
) |
Vacation accrual policy change5 |
|
(2.9 |
) |
|
(2.2 |
) |
|
(2.9 |
) |
|
(2.2 |
) |
Environmental charges at |
|
0.1 |
|
|
0.1 |
|
|
0.2 |
|
|
0.2 |
|
COVID-19-related expenses, net of relief 2 |
|
(0.1 |
) |
|
(0.1 |
) |
|
0.1 |
|
|
0.1 |
|
Total for Aluminum Extrusions |
$ |
(3.5 |
) |
$ |
(2.7 |
) |
$ |
(3.2 |
) |
$ |
(2.4 |
) |
|
|
|
|
|
||||||||
(Gains) losses associated with plant shutdowns, asset impairments and restructurings: |
|
|
|
|
||||||||
Other restructuring costs - severance |
$ |
0.3 |
|
$ |
0.3 |
|
$ |
0.4 |
|
$ |
0.3 |
|
(Gain) losses from sale of assets, investment writedowns and other items: |
|
|
|
|
||||||||
Vacation accrual policy change5 |
|
(0.5 |
) |
|
(0.4 |
) |
|
(0.5 |
) |
|
(0.4 |
) |
COVID-19-related expenses2 |
|
0.1 |
|
|
0.1 |
|
|
0.5 |
|
|
0.3 |
|
Total for |
$ |
(0.1 |
) |
$ |
— |
|
$ |
0.4 |
|
$ |
0.2 |
|
|
|
|
|
|
||||||||
(Gains) losses from sale of assets, investment writedowns and other items: |
|
|
|
|
||||||||
One-time tax credit in |
$ |
— |
|
$ |
— |
|
$ |
(8.5 |
) |
$ |
(6.6 |
) |
COVID-19-related expenses2 |
|
0.1 |
|
|
0.1 |
|
|
0.1 |
|
|
0.1 |
|
Total for |
$ |
0.1 |
|
$ |
0.1 |
|
$ |
(8.4 |
) |
$ |
(6.5 |
) |
Corporate: |
|
|
|
|
||||||||
(Gains) losses associated with plant shutdowns, asset impairments and restructurings: |
|
|
|
|
||||||||
Costs, net of gain associated with the sale of the |
$ |
(0.1 |
) |
$ |
(0.1 |
) |
$ |
0.1 |
|
$ |
0.1 |
|
Other restructuring costs - severance |
|
0.2 |
|
|
0.1 |
|
|
0.2 |
|
|
0.1 |
|
(Gain) losses from sale of assets, investment writedowns and other items: |
|
|
|
|
||||||||
Professional fees associated with business development activities and other1 |
|
1.6 |
|
|
1.3 |
|
|
3.9 |
|
|
3.1 |
|
Professional fees associated with internal control over financial reporting1 |
|
1.2 |
|
|
0.9 |
|
|
3.1 |
|
|
2.3 |
|
Write-down of investment in |
|
— |
|
|
— |
|
|
0.5 |
|
|
0.4 |
|
Stock compensation expense associated with the fair value remeasurement of awards granted at the time of the 2020 Special Dividend1 |
|
— |
|
|
— |
|
|
0.4 |
|
|
0.3 |
|
Transition service fees, net of corporate costs associated with the divested |
|
0.2 |
|
|
0.1 |
|
|
(0.3 |
) |
|
(0.2 |
) |
Vacation accrual policy change5 |
|
(0.4 |
) |
|
(0.3 |
) |
|
(0.4 |
) |
|
(0.3 |
) |
Tax benefit associated with the release of a deferred tax valuation allowance on excess capital losses primarily due to sale of kaléo7 |
|
— |
|
|
(5.5 |
) |
|
— |
|
|
(5.4 |
) |
Total for Corporate |
$ |
2.7 |
|
$ |
(3.5 |
) |
$ |
7.5 |
|
$ |
0.4 |
|
1. Included in “Selling, R&D and general expenses” in the condensed consolidated statements of income.
|
|
Three Months Ended
|
Year Ended |
|||||||||
($ in millions) |
Pre-Tax |
Net of Tax |
Pre-Tax |
Net of Tax |
|||||||
Aluminum Extrusions: |
|
|
|
|
|||||||
(Gains) losses from sale of assets, investment writedowns and other items: |
|
|
|
|
|||||||
Consulting expenses for ERP feasibility study2 |
$ |
0.1 |
|
$ |
0.1 |
|
$ |
1.3 |
$ |
1.0 |
|
Environmental charges at |
|
0.3 |
|
|
0.3 |
|
|
0.3 |
|
0.3 |
|
COVID-19-related expenses3 |
|
0.5 |
|
|
0.3 |
|
|
1.9 |
|
1.4 |
|
Total for Aluminum Extrusions |
$ |
0.9 |
|
$ |
0.7 |
|
$ |
3.5 |
$ |
2.7 |
|
|
|
|
|
|
|||||||
(Gains) losses associated with plant shutdowns, asset impairments and restructurings: |
|
|
|
|
|||||||
Surface Protection restructuring costs - severance |
$ |
1.6 |
|
$ |
1.2 |
|
$ |
1.6 |
$ |
1.2 |
|
(Gain) losses from sale of assets, investment writedowns and other items: |
|
|
|
|
|||||||
COVID-19-related expenses3 |
|
0.2 |
|
|
0.1 |
|
|
0.3 |
|
0.3 |
|
Total for |
$ |
1.8 |
|
$ |
1.3 |
|
$ |
1.9 |
$ |
1.5 |
|
Corporate: |
|
|
|
|
|||||||
(Gain) losses from sale of assets, investment writedowns and other items: |
|
|
|
|
|||||||
Professional fees associated with business development activities and other2 |
$ |
0.3 |
|
$ |
0.1 |
|
$ |
3.5 |
$ |
2.8 |
|
Professional fees associated with internal control over financial reporting and implementation of new accounting guidance2 |
|
1.0 |
|
|
0.7 |
|
|
2.0 |
|
1.4 |
|
Accelerated recognition of stock option-based compensation2 |
|
— |
|
|
— |
|
|
0.1 |
|
0.1 |
|
Corporate costs associated with the divested Personal Care business2 |
|
(0.3 |
) |
|
(0.2 |
) |
|
0.9 |
|
0.7 |
|
Allocation of changes in effective state tax rates resulting primarily from the sale of |
|
— |
|
|
(1.5 |
) |
|
— |
|
(1.5 |
) |
Loss on sale of Bright View Technologies3 |
|
2.3 |
|
|
1.8 |
|
|
2.3 |
|
1.8 |
|
Write-down of investment in |
|
0.1 |
|
|
0.1 |
|
|
0.4 |
|
0.3 |
|
|
|
— |
|
|
— |
|
|
— |
|
(0.6 |
) |
Stock compensation expense associated with the fair value remeasurement of awards granted at the time of the Special Dividend2 |
|
0.4 |
|
|
0.3 |
|
|
0.4 |
|
0.3 |
|
Total for Corporate |
$ |
3.8 |
|
$ |
1.3 |
|
$ |
9.6 |
$ |
5.3 |
|
1. Included in “Cost of goods sold” in the condensed consolidated statements of income. 2. Included in “Selling, R&D and general expenses” in the condensed consolidated statements of income. 3. Included in “Other income (expense), net” in the condensed consolidated statements of income. 4. Included in "Income tax expense (benefit)" in the condensed consolidated statements of income. |
(d) A pre-tax gain of
(e) In the first quarter of 2020, the operations of Aluminum Extrusions’
(f) Tredegar’s presentation of net income (loss) from ongoing operations is a non-GAAP financial measure that excludes the effects of gains or losses associated with plant shutdowns, asset impairments and restructurings, gains or losses from the sale of assets, goodwill impairment charges, and other items (which includes gains and losses for an investment accounted for under the fair value method), which has been presented separately and removed from net income (loss) from continuing operations as reported under GAAP. Net income (loss) from ongoing operations is a key financial and analytical measure used by management to gauge the operating performance of Tredegar’s ongoing operations. It is not intended to represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income (loss) from continuing operations as defined by GAAP. It excludes items that we believe do not relate to Tredegar’s ongoing operations.
Reconciliations of the pre-tax and post-tax balances attributed to net income (loss) from ongoing operations for the three and twelve ended
(In millions) |
Pre-Tax |
|
Taxes Expense
|
|
After-Tax |
|
Effective
|
|||||||
Three Months Ended |
(a) |
|
(b) |
|
|
|
(b)/(a) |
|||||||
Net income (loss) from continuing operations reported under GAAP |
$ |
19.9 |
|
|
$ |
(1.5 |
) |
|
$ |
21.4 |
|
|
(7.5 |
) % |
Losses associated with plant shutdowns, asset impairments and restructurings |
|
0.4 |
|
|
|
0.1 |
|
|
|
0.3 |
|
|
|
|
(Gains) losses from sale of assets and other |
|
(12.7 |
) |
|
|
2.8 |
|
|
|
(15.5 |
) |
|
|
|
Net income (loss) from ongoing operations |
$ |
7.6 |
|
|
$ |
1.4 |
|
|
$ |
6.2 |
|
|
18.4 |
% |
Three Months Ended |
|
|
|
|
|
|
|
|||||||
Net income (loss) from continuing operations reported under GAAP |
$ |
6.6 |
|
|
$ |
0.1 |
|
|
$ |
6.5 |
|
|
1.5 |
% |
Losses associated with plant shutdowns, asset impairments and restructurings |
|
1.6 |
|
|
|
0.4 |
|
|
|
1.2 |
|
|
|
|
(Gains) losses from sale of assets and other |
|
4.8 |
|
|
|
2.8 |
|
|
|
2.0 |
|
|
|
|
Net income (loss) from ongoing operations |
$ |
13.0 |
|
|
$ |
3.3 |
|
|
$ |
9.7 |
|
|
25.4 |
% |
Year Ended |
|
|
|
|
|
|
|
|||||||
Net income (loss) from continuing operations reported under GAAP |
$ |
67.2 |
|
|
$ |
9.3 |
|
|
$ |
57.9 |
|
|
13.8 |
% |
Losses associated with plant shutdowns, asset impairments and restructurings |
|
0.7 |
|
|
|
0.2 |
|
|
|
0.5 |
|
|
|
|
(Gains) losses from sale of assets and other |
|
(17.2 |
) |
|
|
1.6 |
|
|
|
(18.8 |
) |
|
|
|
Net income (loss) from ongoing operations |
$ |
50.7 |
|
|
$ |
11.1 |
|
|
$ |
39.6 |
|
|
21.9 |
% |
Year Ended |
|
|
|
|
|
|
|
|||||||
Net income (loss) from continuing operations reported under GAAP |
$ |
(25.0 |
) |
|
$ |
(8.2 |
) |
|
$ |
(16.8 |
) |
|
32.8 |
% |
Losses associated with plant shutdowns, asset impairments and restructurings |
|
1.6 |
|
|
|
0.4 |
|
|
|
1.2 |
|
|
|
|
(Gains) losses from sale of assets and other |
|
74.3 |
|
|
|
18.4 |
|
|
|
55.9 |
|
|
|
|
|
|
13.7 |
|
|
|
3.2 |
|
|
|
10.5 |
|
|
|
|
Net income (loss) from ongoing operations |
$ |
64.6 |
|
|
$ |
13.8 |
|
|
$ |
50.8 |
|
|
21.4 |
% |
(g) Net debt is calculated as follows:
(in millions) |
|
|
|
|
||
|
|
2021 |
|
|
2020 |
|
Debt |
|
$ |
73.0 |
|
$ |
134.0 |
Less: Cash and cash equivalents |
|
|
30.5 |
|
|
11.8 |
Net debt |
|
$ |
42.5 |
|
$ |
122.2 |
Net debt is not intended to represent total debt as defined by GAAP. Net debt is utilized by management in evaluating the Company’s financial leverage and equity valuation, and management believes that investors also may find net debt to be helpful for the same purposes.
(h) Represents a one-time tax credit in
(i) In
(j) During the fourth quarter of 2021, the Company recorded an out-of-period adjustment in connection with the original valuation of intangible assets and goodwill related to the acquisition of Futura in
View source version on businesswire.com: https://www.businesswire.com/news/home/20220311005038/en/
neill.bellamy@tredegar.com
Source:
FAQ
What were Tredegar's fourth quarter earnings per share for 2021?
How did Tredegar's full year net income change from 2020 to 2021?
What challenges is Tredegar facing in its operations?
What decline did Tredegar experience in its PE Films segment for 2021?